136 related articles for article (PubMed ID: 37265422)
21. Correlation between early postnatal body weight changes and lung ultrasound scores as predictors of bronchopulmonary dysplasia in preterm infants: A secondary analysis of a prospective study.
Ghanem M; Zozaya C; Ibrahim J; Lee S; Mohsen N; Nasef N; Mohamed A
Eur J Pediatr; 2024 May; 183(5):2123-2130. PubMed ID: 38363393
[TBL] [Abstract][Full Text] [Related]
22. Natural evolution of the patent ductus arteriosus in the extremely premature newborn and respiratory outcomes.
de Carvalho Nunes G; Wutthigate P; Simoneau J; Beltempo M; Sant'Anna GM; Altit G
J Perinatol; 2022 May; 42(5):642-648. PubMed ID: 34815521
[TBL] [Abstract][Full Text] [Related]
23. Risk factors associated with prolonged mechanical ventilation after surgical patent ductus arteriosus ligation in preterm infants.
Seo YM; Sung IK; Yum SK
J Matern Fetal Neonatal Med; 2022 Oct; 35(19):3714-3721. PubMed ID: 33111604
[TBL] [Abstract][Full Text] [Related]
24. The Aristotle score predicts mortality after surgery of patent ductus arteriosus in preterm infants.
Chang YH; Lee JY; Kim JE; Kim JY; Youn Y; Lee EJ; Moon S; Lee JY; Sung IK
Ann Thorac Surg; 2013 Sep; 96(3):879-84. PubMed ID: 23895892
[TBL] [Abstract][Full Text] [Related]
25. N-Terminal Pro-B Type Natriuretic Peptide as a Marker of Bronchopulmonary Dysplasia or Death in Very Preterm Neonates: A Cohort Study.
Sellmer A; Hjortdal VE; Bjerre JV; Schmidt MR; McNamara PJ; Bech BH; Henriksen TB
PLoS One; 2015; 10(10):e0140079. PubMed ID: 26452045
[TBL] [Abstract][Full Text] [Related]
26. Indomethacin for symptomatic patent ductus arteriosus in preterm infants.
Evans P; O'Reilly D; Flyer JN; Soll R; Mitra S
Cochrane Database Syst Rev; 2021 Jan; 1(1):CD013133. PubMed ID: 33448032
[TBL] [Abstract][Full Text] [Related]
27. Lung Ultrasound Score Predicts the Extravascular Lung Water Content in Low-Birth-Weight Neonates with Patent Ductus Arteriosus.
Zhao M; Huang XM; Niu L; Ni WX; Zhang ZQ
Med Sci Monit; 2020 Jun; 26():e921671. PubMed ID: 32538377
[TBL] [Abstract][Full Text] [Related]
28. The role of patent ductus arteriosus ligation in bronchopulmonary dysplasia: reexamining a randomized controlled trial.
Clyman R; Cassady G; Kirklin JK; Collins M; Philips JB
J Pediatr; 2009 Jun; 154(6):873-6. PubMed ID: 19324366
[TBL] [Abstract][Full Text] [Related]
29. Therapeutic strategy of patent ductus arteriosus in extremely preterm infants.
Su BH; Lin HY; Chiu HY; Tsai ML; Chen YT; Lu IC
Pediatr Neonatol; 2020 Apr; 61(2):133-141. PubMed ID: 31740267
[TBL] [Abstract][Full Text] [Related]
30. Comparison of the Mortality and In-Hospital Outcomes of Preterm Infants Treated with Ibuprofen for Patent Ductus Arteriosus with or without Clinical Symptoms Attributable to the Patent Ductus Arteriosus at the Time of Ibuprofen Treatment.
Yoo H; Lee JA; Oh S; Jung YH; Sohn JA; Shin SH; Choi CW; Kim EK; Kim HS; Kim BI
J Korean Med Sci; 2017 Jan; 32(1):115-123. PubMed ID: 27914140
[TBL] [Abstract][Full Text] [Related]
31. Predictors of Respiratory Improvement 1 Week after Ligation of Patent Ductus Arteriosus in Preterm Infants.
Hsu KH; Wong P; Ram Kumar S; Evans J; Noori S
J Pediatr; 2019 Feb; 205():49-54.e2. PubMed ID: 30348438
[TBL] [Abstract][Full Text] [Related]
32. Morbidities associated with patent ductus arteriosus in preterm infants. Nationwide cohort study.
Härkin P; Marttila R; Pokka T; Saarela T; Hallman M
J Matern Fetal Neonatal Med; 2018 Oct; 31(19):2576-2583. PubMed ID: 28651469
[TBL] [Abstract][Full Text] [Related]
33. Patent ductus arteriosus ligation in premature infants: who really benefits, and at what cost?
Raval MV; Laughon MM; Bose CL; Phillips JD
J Pediatr Surg; 2007 Jan; 42(1):69-75; discussion 75. PubMed ID: 17208543
[TBL] [Abstract][Full Text] [Related]
34. Timing of pharmacological treatment for patent ductus arteriosus and risk of secondary surgery, death or bronchopulmonary dysplasia: a population-based cohort study of extremely preterm infants.
Gudmundsdottir A; Johansson S; Håkansson S; Norman M; Källen K; Bonamy AK
Neonatology; 2015; 107(2):87-92. PubMed ID: 25412681
[TBL] [Abstract][Full Text] [Related]
35. Prophylactic Indomethacin Compared with Delayed Conservative Management of the Patent Ductus Arteriosus in Extremely Preterm Infants: Effects on Neonatal Outcomes.
Liebowitz M; Clyman RI
J Pediatr; 2017 Aug; 187():119-126.e1. PubMed ID: 28396025
[TBL] [Abstract][Full Text] [Related]
36. Duration of significant patent ductus arteriosus and bronchopulmonary dysplasia in extremely preterm infants.
Mirza H; Garcia J; McKinley G; Hubbard L; Sensing W; Schneider J; Oh W; Wadhawan R
J Perinatol; 2019 Dec; 39(12):1648-1655. PubMed ID: 31554913
[TBL] [Abstract][Full Text] [Related]
37. [Timing of surgical ligation of patent ductus arteriosus in very low birth weight infants].
Liu TX; Ma XL; Chen Z; Shi LP
Zhongguo Dang Dai Er Ke Za Zhi; 2022 May; 24(5):500-506. PubMed ID: 35644189
[TBL] [Abstract][Full Text] [Related]
38. Surgical versus medical treatment with cyclooxygenase inhibitors for symptomatic patent ductus arteriosus in preterm infants.
Malviya M; Ohlsson A; Shah S
Cochrane Database Syst Rev; 2008 Jan; (1):CD003951. PubMed ID: 18254035
[TBL] [Abstract][Full Text] [Related]
39. Patent ductus arteriosus ligation is associated with impaired left ventricular systolic performance in premature infants weighing less than 1000 g.
McNamara PJ; Stewart L; Shivananda SP; Stephens D; Sehgal A
J Thorac Cardiovasc Surg; 2010 Jul; 140(1):150-7. PubMed ID: 20363478
[TBL] [Abstract][Full Text] [Related]
40. Effects of therapeutic approach on the neonatal evolution of very low birth weight infants with patent ductus arteriosus.
Sadeck LS; Leone CR; Procianoy RS; Guinsburg R; Marba ST; Martinez FE; Rugolo LM; Moreira ME; Fiori RM; Ferrari LL; Menezes JA; Venzon PS; Abdallah VQ; Duarte JL; Nunes MV; Anchieta LM; Alves Filho N
J Pediatr (Rio J); 2014; 90(6):616-23. PubMed ID: 25046256
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
